無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

オーソバイオロジクスの世界市場の将来展望

Global Orthobiologics Market Outlook 2020

発行 RNCOS E-Services Pvt. Ltd. 商品コード 356647
出版日 ページ情報 英文 120 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.41円で換算しております。
Back to Top
オーソバイオロジクスの世界市場の将来展望 Global Orthobiologics Market Outlook 2020
出版日: 2016年04月01日 ページ情報: 英文 120 Pages
概要

オーソバイオロジクス (orthobiologics) とは、人体由来・天然性の材料を用いた整形外科処置のことを指します。治癒・回復速度が速いことや、入院日数が短くなることから、現在急速に需要が拡大しており、また様々な分野で活用されるようになってきました。2015年現在、世界のオーソバイオロジクスの市場規模は約40億米ドルと推計されています。関節炎などの整形外科疾患の有病者数の増加や、高齢者人口の増大、肥満症の蔓延などが、市場成長の主な要因となっています。他方、治療コストの高さや複雑な規制枠組み、骨形成タンパク質 (BMP) の生物的適合性の問題などが、市場成長の妨げとなる可能性があります。

当レポートでは、世界のオーソバイオロジクス市場について分析し、市場・製品の概要や、主な市場促進・抑制要因、製品種類別・用途別・地域別の市場動向見通し (今後6年間分)、市場競争の概況、主要企業のプロファイル・最新情勢などについて調査・推計しております。

第1章 アナリストの見解

第2章 分析手法

第3章 オーソバイオロジクス:概略

第4章 市場のダイナミクス

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の傾向

第5章 世界のオーソバイオロジクス市場の将来展望 (2020年まで)

第6章 世界のオーソバイオロジクス市場:製品種類別の市場規模

  • 骨形成タンパク質 (BMP)
  • 脱灰骨基質 (DBM)
  • 代用骨移植片
  • 同種骨移植片
  • 幹細胞療法
  • 機械加工骨
  • 関節内補充薬

第7章 世界のオーソバイオロジクス市場:用途別の市場規模

  • 脊椎固定手術
  • 再建手術
  • 外傷手術

第8章 世界のオーソバイオロジクス市場:地域別の市場規模

  • 北米
  • 欧州
  • アジア
  • 他の国々 (RoW)

第9章 パイプライン分析

第10章 競争環境

第11章 主要企業の分析

  • Zimmer Biomet
  • Stryker Corporation
  • DePuy Synthes, Inc. (Johnson & Johnsonの子会社)
  • Medtronic plc
  • Smith & Nephew Plc
  • Orthofix International N.V
  • Wright Medical Group N.V
  • Integra Life Sciences Corporation
  • NuVasive, Inc.
  • Globus Medical, Inc.
目次

Orthobiologics finds extensive application in various orthopedic diseases treatment. The orthobiologics are made utilizing substances found naturally in the human body. These products are increasing in demand as they provide quick healing, faster recovery, and lesser number of hospital visits.

According to RNCOS' new research report "Global Orthobiologics Market Outlook 2020", the orthobiologics market was valued around US$ 4 Billion in 2015. The major reason for the growth of the market is the increasing adoption of orthobiologics, especially bone graft substitutes in different orthopedic applications. In addition, rise in the incidence of arthritis and other orthopedic diseases, increase in geriatric population and increase in obesity rate has triggered the growth of this market. However, factors such as high cost of the orthobiologics and orthopedic procedures, complex regulatory framework, and the biocompatibility issues associated with bone morphogenetic proteins are expected to hamper the market growth in the forecasted period.

RNCOS, in its report has segmented the global orthobiologics market on the basis of product type, application, and geography. Viscosupplementation accounts for the largest share of the orthobiologics products market. Synthetic bone substitutes and stem cell based products are expected to witness a significant growth due to increasing number of research related activities in the stem cell orthobiologics market. Furthermore, the report also provides insights about the orthobiologics products that are in developmental stages.

Based on applications, the orthobiologics market is divided into spinal fusion, trauma and reconstructive surgery. Spinal fusion accounted for the largest share of the market owing to increasing number of spinal fusion surgeries. The reconstructive surgery market is poised to witness highest growth due to rising number of hip and knee replacement surgeries.

The market has been divided into four major regions to provide a regional analysis of the orthobiologics market: North America, Europe, Asia, and Rest of the World. Of these, North America is currently the largest market for orthobiologics owing to a high prevalence of obesity and arthritis, and higher healthcare expenditure in the region. The high share is also attributed to the wide acceptance of orthobiologics products, coupled with launch of new and advanced products in the market. The Asian market is poised to witness the highest growth in the forecasted period due to increasing focus of players in this region, and also as a result of an expanding geriatric population base and increasing number of road accidents.

After an exhaustive study of the industry, the report presents a deep dive competitive landscape covering the top players along with recent developments (new product launches and partnerships, mergers and acquisitions, and joint ventures) and growth strategies adopted by them to sustain their position in the global orthobiologics market. Zimmer Biomet, Medtronic plc, Stryker Corporation, DePuy Synthes, Inc., Smith & Nephew plc, and Wright Medical Group N.V. are some of the leading players in the global orthobiologics market.

Table of Contents

1. Analyst View

2. Research Methodology

3. Orthobiologics: An Introduction

4. Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Growing Geriatric Population
    • 4.1.2 Surge in the Number of Orthopedic Surgeries
    • 4.1.3 Rampant Usage of Bone Grafts Substitutes in Various Applications
    • 4.1.4 Growing Usage of Biologic Solutions in Sports Medicine
    • 4.1.5 Increasing Acceptance of Orthobiological Products
    • 4.1.6 Rising Incidence of Obesity and Orthopedic Diseases
    • 4.1.7 Technological Advancements
  • 4.2 Market Restraints
    • 4.2.1 High cost of Orthobiologics and Orthopedic procedures
    • 4.2.2 Less-Defined Regulatory Environment
    • 4.2.3 Biocompatibility Issues
    • 4.2.4 Lack of Clinical Data
  • 4.3 Market Opportunities
    • 4.3.1 Rising Orthobiologics Utility in Fracture Healing
    • 4.3.2 Bone Grafts and Substitutes Offers Significant Growth Opportunity
    • 4.3.3 High Growth Asian Market
  • 4.4 Market Trends
    • 4.4.1 Growing Interest of Venture Capitalist Firms In Orthobiologics
    • 4.4.2 Rise in Strategic Alliances in Orthobiologics Market
    • 4.4.3 Soft Tissue Repair: Gaining Momentum

5. Global Orthobiologics Market Outlook to 2020

6. Global Orthobiologics Market Size by Product Type

  • 6.1 Bone Morphogenetic Proteins (BMP)
  • 6.2 Demineralized Bone Matrix (DBM)
  • 6.3 Synthetic Bone Substitutes
  • 6.4 Bone Allografts
  • 6.5 Stem Cell Therapy
  • 6.6 Machined Bones
  • 6.7 Viscosupplementation

7. Global Orthobiologics Market Size by Applications

  • 7.1 Spinal Fusion Surgery
  • 7.2 Reconstructive Surgery
  • 7.3 Trauma Surgery

8. Global Orthobiologics Market Size by Geography

  • 8.1 North America
  • 8.2 Europe
  • 8.3 Asia
  • 8.4 Rest of the World (RoW)

9. Pipeline Analysis

10. Competitive Landscape

11. Key Player Analysis

  • 11.1 Zimmer Biomet
  • 11.2 Stryker Corporation
  • 11.3 DePuy Synthes, Inc. (A Subsidiary of Johnson & Johnson)
  • 11.4 Medtronic plc
  • 11.5 Smith & Nephew Plc
  • 11.6 Orthofix International N.V
  • 11.7 Wright Medical Group N.V
  • 11.8 Integra Life Sciences Corporation
  • 11.9 NuVasive, Inc.
  • 11.10 Globus Medical, Inc.

List of Figures:

  • Figure 4-1: Global - Population above 60 Years (Billion), 2013 & 2050
  • Figure 5-1: Global - Orthobiologics Market (Million US$), 2015-2020
  • Figure 6-1: Global - Orthobiologics Market by Product Type (%), 2015
  • Figure 6-2: Global - Orthobiologics Market by Product Type (%), 2020
  • Figure 6-3: Global - Orthobiologics Market for Bone Morphogenetic Proteins (Million US$), 2015-2020
  • Figure 6-4: Global - Orthobiologics Market for Demineralized Bone Matrix (Million US$), 2015-2020
  • Figure 6-5: Global - Orthobiologics Market for Synthetic Bone Substitutes (Million US$), 2015-2020
  • Figure 6-6: Global - Orthobiologics Market for Bone Allografts (Million US$), 2015-2020
  • Figure 6-7: Global - Orthobiologics Market for Stem Cell Therapy (Million US$), 2015-2020
  • Figure 6-8: Global - Orthobiologics Market for Machined Bones (Million US$), 2015-2020
  • Figure 6-9: Global - Orthobiologics Market for Viscosupplementation (Million US$), 2015-2020
  • Figure 7-1: Global - Orthobiologics Market by Application (%), 2015
  • Figure 7-2: Global - Orthobiologics Market by Application (%), 2020
  • Figure 7-3: Global - Orthobiologics Spinal Fusion Surgery Market (Million US$), 2015-2020
  • Figure 7-4: Global - Orthobiologics Reconstructive Surgery Market (Million US$), 2015-2020
  • Figure 7-5: Global - Orthobiologics Trauma Surgery Market (Million US$), 2015-2020
  • Figure 8-1: Global - Orthobiologics Market by Geography (%), 2015
  • Figure 8-2: Global - Orthobiologics Market by Geography (%), 2020
  • Figure 8-3: North America - Orthobiologics Market (Million US$), 2015-2020
  • Figure 8-4: Europe - Orthobiologics Market (Million US$), 2015-2020
  • Figure 8-5: Asia - Orthobiologics Market (Million US$), 2015-2020
  • Figure 8-6: Rest of the World - Orthobiologics Market (Million US$), 2015-2020
  • Figure 10-1: Global - Share of Major Players in Orthobiologics Market (%), 2015
  • Figure 11-1: Zimmer Biomet - Breakup of Revenue by Region (%), 2015
  • Figure 11-2: Stryker Corporation - Breakup of Revenue by Region (%), 2015
  • Figure 11-3: Johnson & Johnson - Breakup of Revenue by Region (%), 2015
  • Figure 11-4: Medtronic plc - Breakup of Revenue by Region (%), 2015
  • Figure 11-5: Smith & Nephew plc - Breakup of Revenue by Region (%), 2015
  • Figure 11-6: Orthofix International N.V. - Breakup of Revenue by Region (%), 2015
  • Figure 11-7: Wright Medical Group N.V. - Breakup of Revenue by Region (%), 2015
  • Figure 11-8: Integra Life Sciences Corporation - Breakup of Revenue by Region (%), 2014
  • Figure 11-9: NuVasive, Inc. - Breakup of Revenue by Region (%), 2014
  • Figure 11-10: Globus Medical, Inc. - Breakup of Revenue by Region (%), 2015

List of Tables:

  • Table 4-1: Global - Venture Capitalist Investments (Million US$), 2012-2015
  • Table 4-2: Global - Mergers & Acquisitions
  • Table 4-3: Soft Tissue Repair/Replacement Product Landscape
  • Table 9-1: Global - Orthobiologics Products Pipeline
  • Table 11-1: Zimmer Biomet - Revenue by Product Segment (Million US$), 2013-2015
  • Table 11-2: Zimmer Biomet - Product Portfolio for Orthobiologics Market
  • Table 11-3: Stryker Corporation - Revenue by Product Segment (Million US$), 2013-2015
  • Table 11-4: Stryker Corporation - Product Portfolio for Orthobiologics Market
  • Table 11-5: Johnson & Johnson - Medical Devices Revenue by Product Segment (Million US$), 2013-2015
  • Table 11-6: Johnson & Johnson - Product Portfolio for Orthobiologics Market
  • Table 11-7: Medtronic plc - Revenue by Product Segment (Million US$), 2013-2015
  • Table 11-8: Medtronic plc - Product Portfolio for Orthobiologics Market
  • Table 11-9: Smith & Nephew plc - Revenue by Product Segment (Million US$), 2013-2015
  • Table 11-10: Smith & Nephew plc - Product Portfolio for Orthobiologics Market
  • Table 11-11: Orthofix International N.V. - Revenue by Product Segment (Million US$),2013-2015
  • Table 11-12: Orthofix International N.V. - Product Portfolio for Orthobiologics Market
  • Table 11-13: Wright Medical Group N.V. - Revenue by Product Segment (Million US$), 2013-2015
  • Table 11-14: Wright Medical Group N.V. - Product Portfolio of Biologics for Orthobiologics Market
  • Table 11-15: Integra Life Sciences Corporation - Revenue by Product Segment (Million US$),2012-2014
  • Table 11-16: Integra Life Sciences Corporation - Product Portfolio for Orthobiologics Market
  • Table 11-17: NuVasive, Inc. - Revenue by Product Segment (Million US$), 2012-2014
  • Table 11-18: NuVasive, Inc. - Product Portfolio for Orthobiologics Market
  • Table 11-19: Globus Medical, Inc. - Revenue by Product Segment (Million US$), 2013-2015
  • Table 11-20: Globus Medical Inc. - Product Portfolio for Orthobiologics Market
Back to Top